1. Y. Meng, M. Kujas, Y. Marie, S. Paris, J. Thillet, J. Y. Delattre, and A. F. Carpentier. Expression of TLR9 within human glioblastoma. J Neurooncol, 88(1):19-25, 2008. Note: Journal ArticleResearch Support, Non-U.S. Gov'tNetherlands. [WWW] Keyword(s): Adult, Aged, Animals, Brain Neoplasms/*genetics/metabolism/pathology, Female, Fluorescent Antibody Technique, Glioblastoma/*genetics/metabolism/pathology, Humans, Immunohistochemistry, Karnofsky Performance Status, Lymphocytes/pathology, Male, Mice, Mice, Nude, Middle Aged, Neoplasm Transplantation, Neurosurgical Procedures, RNA, Messenger/biosynthesis/genetics, Reverse Transcriptase Polymerase Chain Reaction, Survival, Toll-Like Receptor 9/*biosynthesis/*genetics.



2. D. Ricard, G. Kaloshi, A. Amiel-Benouaich, J. Lejeune, Y. Marie, E. Mandonnet, M. Kujas, K. Mokhtari, S. Taillibert, F. Laigle-Donadey, A. F. Carpentier, A. Omuro, L. Capelle, H. Duffau, P. Cornu, R. Guillevin, M. Sanson, K. Hoang-Xuan, and J. Y. Delattre. Dynamic history of low-grade gliomas before and after temozolomide treatment. Ann Neurol, 61(5):484-90, 2007. Note: Journal ArticleUnited States. [WWW]



3. A. F. Carpentier and Y. Meng. Recent advances in immunotherapy for human glioma. Curr Opin Oncol, 18(6):631-6, 2006. Note: Journal ArticleUnited States. [WWW]



4. M. J. van den Bent, A. F. Carpentier, A. A. Brandes, M. Sanson, M. J. Taphoorn, H. J. Bernsen, M. Frenay, C. C. Tijssen, W. Grisold, L. Sipos, H. Haaxma-Reiche, J. M. Kros, M. C. van Kouwenhoven, C. J. Vecht, A. Allgeier, D. Lacombe, and T. Gorlia. Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial. J Clin Oncol, 24(18):2715-22, 2006. Note: Clinical Trial, Phase IIIJournal ArticleMulticenter StudyRandomized Controlled TrialResearch Support, Non-U.S. Gov'tUnited Statesofficial journal of the American Society of Clinical Oncology. [WWW] Keyword(s): Adult, Aged, Antineoplastic Combined Chemotherapy Protocols/*therapeutic use, Brain Neoplasms/*drug therapy/genetics/radiotherapy, Chemotherapy, Adjuvant, Chromosomes, Human, Pair 1, Chromosomes, Human, Pair 19, Dose Fractionation, Female, Humans, Lomustine/therapeutic use, Loss of Heterozygosity, Male, Middle Aged, Oligodendroglioma/*drug therapy/genetics/radiotherapy, Procarbazine/therapeutic use, Survival Analysis, Vincristine/therapeutic use.



5. L. Aguirre-Cruz, J. L. Charuel, A. F. Carpentier, B. Benyahia, J. Y. Delattre, and L. Musset. Clinical relevance of non-neuronal auto-antibodies in patients with anti-Hu or anti-Yo paraneoplastic diseases. J Neurooncol, 71(1):39-41, 2005. Note: Clinical TrialComparative StudyJournal ArticleNetherlands. [WWW] Keyword(s): Aged, Antibodies, Antinuclear/*immunology, Autoantibodies/*immunology, Breast Neoplasms/immunology, Carcinoma, Small Cell/immunology, DNA-Binding Proteins/*immunology, Female, Hu Paraneoplastic Encephalomyelitis Antigens, Humans, Lung Neoplasms/immunology, Male, Middle Aged, Neoplasm Proteins/*immunology, Neoplasms/*immunology, Nerve Tissue Proteins/*immunology, Neurons/immunology, Ovarian Neoplasms/immunology, Paraneoplastic Syndromes, Nervous System/*immunology, Prostatic Neoplasms/immunology, RNA-Binding Proteins/*immunology, Urologic Neoplasms/immunology.



6. M. Kujas, J. Lejeune, A. Benouaich-Amiel, E. Criniere, F. Laigle-Donadey, Y. Marie, K. Mokhtari, M. Polivka, M. Bernier, F. Chretien, A. Couvelard, L. Capelle, H. Duffau, P. Cornu, P. Broet, J. Thillet, A. F. Carpentier, M. Sanson, K. Hoang-Xuan, and J. Y. Delattre. Chromosome 1p loss: a favorable prognostic factor in low-grade gliomas. Ann Neurol, 58(2):322-6, 2005. Note: Comparative StudyJournal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adolescent, Adult, Aged, Brain Neoplasms/*genetics/pathology, *Chromosome Deletion, *Chromosomes, Human, Pair 1, Chromosomes, Human, Pair 19, Female, Glioma/*genetics/pathology, Humans, Immunohistochemistry/methods, *Loss of Heterozygosity, Male, Middle Aged, Molecular Biology/methods.



7. Y. Marie, A. F. Carpentier, A. M. Omuro, M. Sanson, J. Thillet, K. Hoang-Xuan, and J. Y. Delattre. EGFR tyrosine kinase domain mutations in human gliomas. Neurology, 64(8):1444-5, 2005. Note: Journal ArticleUnited States. [WWW] Keyword(s): Astrocytoma/drug therapy/enzymology/genetics, Brain Neoplasms/drug therapy/*enzymology/*genetics, Carcinoma/drug therapy/enzymology/genetics, DNA Mutational Analysis, Drug Resistance, Neoplasm/genetics, Genetic Screening, Glioblastoma/drug therapy/enzymology/genetics, Glioma/drug therapy/*enzymology/*genetics, Humans, Lung Neoplasms/drug therapy/enzymology/genetics, Mutation/*genetics, Oligodendroglioma/drug therapy/enzymology/genetics, Protein Kinase Inhibitors/pharmacology/therapeutic use, Protein Structure, Tertiary/genetics, Quinazolines/pharmacology/therapeutic use, Receptor, Epidermal Growth Factor/*genetics.



8. Y. Meng, A. F. Carpentier, L. Chen, G. Boisserie, J. M. Simon, J. J. Mazeron, and J. Y. Delattre. Successful combination of local CpG-ODN and radiotherapy in malignant glioma. Int J Cancer, 116(6):992-7, 2005. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Animals, Cell Division/drug effects/radiation effects, Cell Line, Tumor, Combined Modality Therapy, Dinucleoside Phosphates/*therapeutic use, Disease Models, Animal, Gene Therapy/methods, Glioma/*drug therapy/genetics/*radiotherapy, Humans, Oligodeoxyribonucleotides/*therapeutic use, Rats, Rats, Inbred F344.



9. K. Hoang-Xuan, L. Capelle, M. Kujas, S. Taillibert, H. Duffau, J. Lejeune, M. Polivka, E. Criniere, Y. Marie, K. Mokhtari, A. F. Carpentier, F. Laigle, J. M. Simon, P. Cornu, P. Broet, M. Sanson, and J. Y. Delattre. Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions. J Clin Oncol, 22(15):3133-8, 2004. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited Statesofficial journal of the American Society of Clinical Oncology. [WWW] Keyword(s): Adult, Aged, Antineoplastic Agents, Alkylating/*therapeutic use, Astrocytoma/*drug therapy/*genetics, Brain Neoplasms/*drug therapy/*genetics, *Chromosome Deletion, Chromosomes, Human, Pair 1/*genetics, Dacarbazine/*analogs & derivatives/*therapeutic use, Female, Humans, Loss of Heterozygosity, Magnetic Resonance Imaging, Male, Middle Aged, Oligodendroglioma/*drug therapy/*genetics.



10. A. Llado, P. Mannucci, A. F. Carpentier, S. Paris, Y. Blanco, A. Saiz, J. Y. Delattre, and F. Graus. Value of Hu antibody determinations in the follow-up of paraneoplastic neurologic syndromes. Neurology, 63(10):1947-9, 2004. Note: Evaluation StudiesJournal ArticleResearch Support, Non-U.S. Gov'tReviewUnited States. [WWW] Keyword(s): Adult, Aged, Aged, 80 and over, Autoantibodies/*blood/immunology, Autoantigens/*immunology, Carcinoid Tumor/complications/immunology/therapy, Carcinoma, Small Cell/complications/immunology/therapy, Disease Progression, Female, Follow-Up Studies, Hu Paraneoplastic Encephalomyelitis Antigens, Humans, Lung Neoplasms/complications/immunology/therapy, Male, Middle Aged, Nerve Tissue Proteins/*immunology, Paraneoplastic Syndromes, Nervous System/blood/*immunology, Predictive Value of Tests, RNA-Binding Proteins/*immunology, Retrospective Studies, Treatment Outcome.



11. A. Behin, K. Hoang-Xuan, A. F. Carpentier, and J. Y. Delattre. Primary brain tumours in adults. Lancet, 361(9354):323-31, 2003. Note: Journal ArticleResearch Support, Non-U.S. Gov'tReviewEngland. [WWW] Keyword(s): Adult, *Brain Neoplasms/classification/diagnosis/genetics/physiopathology, Combined Modality Therapy, *Glioma/classification/diagnosis/genetics/physiopathology, Humans, Magnetic Resonance Imaging, Molecular Biology.



12. B. Benyahia, A. F. Carpentier, and J. Y. Delattre. [Antineuron antibodies and paraneoplastic neurological syndromes]. Rev Neurol (Paris), 159(4):463-5, 2003. Note: Journal ArticleReviewFrance. [WWW] Keyword(s): Animals, Antibody Specificity, Autoantibodies/blood/*immunology, Autoantigens/immunology, Autoimmune Diseases/*immunology, Blotting, Western, Fluorescent Antibody Technique, Indirect, Humans, Nerve Tissue Proteins/immunology, Nervous System Diseases/*immunology, Neurons/*immunology, Paraneoplastic Syndromes/*immunology, Rats.



13. A. F. Carpentier, G. Auf, and J. Y. Delattre. CpG-oligonucleotides for cancer immunotherapy : review of the literature and potential applications in malignant glioma. Front Biosci, 8:e115-27, 2003. Note: Journal ArticleResearch Support, Non-U.S. Gov'tReviewUnited Statesa journal and virtual library. [WWW] Keyword(s): Adjuvants, Immunologic/*therapeutic use, Animals, Central Nervous System Neoplasms/immunology/*therapy, CpG Islands/*immunology, Glioma/immunology/*therapy, Humans, Immunotherapy, Active/*methods, Oligodeoxyribonucleotides/*therapeutic use.



14. E. Louis, N. Martin-Duverneuil, A. F. Carpentier, J. M. Mayer, and J. Y. Delattre. [Radiation-induced aneurysm of the cavernous internal carotid artery]. Rev Neurol (Paris), 159(3):319-22, 2003. Note: Case ReportsEnglish AbstractJournal ArticleFrance. [WWW] Keyword(s): Carotid Artery, Internal/pathology/*physiopathology/radiography, Cerebral Angiography, Functional Laterality/*physiology, Hodgkin Disease/radiotherapy, Humans, Intracranial Aneurysm/*diagnosis/*physiopathology, Magnetic Resonance Imaging, Male, Middle Aged, Radiotherapy/*adverse effects, Tomography, X-Ray Computed.



15. E. Mandonnet, J. Y. Delattre, M. L. Tanguy, K. R. Swanson, A. F. Carpentier, H. Duffau, P. Cornu, R. Van Effenterre, E. C. Jr Alvord, and L. Capelle. Continuous growth of mean tumor diameter in a subset of grade II gliomas. Ann Neurol, 53(4):524-8, 2003. Note: Journal ArticleUnited States. [WWW] Keyword(s): Adult, Brain Neoplasms/*pathology, Cell Division, Female, Follow-Up Studies, Glioma/*pathology, Humans, Linear Models, Magnetic Resonance Imaging, Male, Middle Aged, Oligodendroglioma/*pathology, Retrospective Studies.

This material is presented to ensure timely dissemination of scholarly and technical work. Copyright and all rights therein are retained by authors or by other copyright holders. All person copying this information are expected to adhere to the terms and constraints invoked by each author's copyright. In most cases, these works may not be reposted without the explicit permission of the copyright holder.

Les documents contenus dans ces répertoires sont rendus disponibles par les auteurs qui y ont contribué en vue d'assurer la diffusion à temps de travaux savants et techniques sur une base non-commerciale. Les droits de copie et autres droits sont gardés par les auteurs et par les détenteurs du copyright, en dépit du fait qu'ils présentent ici leurs travaux sous forme électronique. Les personnes copiant ces informations doivent adhérer aux termes et contraintes couverts par le copyright de chaque auteur. Ces travaux ne peuvent pas être rendus disponibles ailleurs sans la permission explicite du détenteur du copyright.

This document was translated from BibT_EX by bibtex2html